Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study

References

• Yang Y, Chengyuan W. Guidelines on the basic outcome data from International Association for the Study of Pain. Clin J Pain 2007;23:549
   PubMedGoogle Scholar
• Manchikanti L, Singh V, Datta S, et al. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009;12:E35-70
   PubMed Web of Science ®Google Scholar
• Cid J, Acuña JP, De Andrés J, et al. How should we evaluate the chronic pain patient? The chronic pain patient evaluation. Rev Med Clin 2014;25:687-97
   Google Scholar
• van den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ, et al. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 2016;51:1070-90
   PubMed Web of Science ®Google Scholar
• Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA 2008;299:656-64
   PubMed Web of Science ®Google Scholar
• Li C, Balluz LS, Okoro CA, et al. Surveillance of certain health behaviors and conditions among states and selected local areas. Behavioral Risk Factor Surveillance System, United States, 2009. Centers for Disease Control and Prevention (CDC). MMWR Surveill Summ 2011;60:1-250
   PubMedGoogle Scholar
• Stewart WF, Ricci JA, Chee E, et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 2003;290:2443-54
   PubMed Web of Science ®Google Scholar
• Davies AN, Dickman A, Reid C, et al.; Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13:331-8
   PubMed Web of Science ®Google Scholar
• Zappetella G, O’Doherty CA, Collins S. Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice. Palliat Med 2001;15:243-6
   PubMed Web of Science ®Google Scholar
• Gómez-Batiste X, Madrid F, Moreno F, et al. Breakthrough cancer pain: prevalence and characteristics in patients in Catalonia, Spain. J Pain Symptom Manage 2002;24:45-52
   PubMed Web of Science ®Google Scholar
• Deandrea S, Corli O, Consonni D, et al. Prevalence of breakthrough pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 2014;47:57-76
   PubMed Web of Science ®Google Scholar
• Fortner BV, Demarco G, Irving G, et al. Description and predictors of direct and indirect costs of pain reported by cancer patients. J Pain Symptom Manage 2003;25:9-18
   PubMed Web of Science ®Google Scholar
• Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 2002;3:38-44
   PubMed Web of Science ®Google Scholar
• Mercadante S. Breakthrough pain in cancer patients: prevalence, mechanisms and treatment options. Curr Opin Anesthesiol 2015;28:559-64
   PubMed Web of Science ®Google Scholar
• McCarberg BH. The treatment of breakthrough pain. Pain Med 2007;8:S8-S13
   PubMed Web of Science ®Google Scholar
• Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps on use of opioids for chronic non-cancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009;10:147-59
   PubMed Web of Science ®Google Scholar
• Guerra de Hoyos JA, Sanz Amores R, Domínguez Camacho JC, et al. Uso seguro de opioides en pacientes en situación terminal: guía de práctica clínica [Safe use of opioids in terminally ill patients: clinical practice guidelines]. Consejería de Salud, Junta de Andalucía, Sevilla, 2010
   Google Scholar
• Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009;20:1420-33
   PubMed Web of Science ®Google Scholar
• Maurish ME (ed.). User’s manual for the SF-12v2 Health Survey, 3rd edn. Lincoln, RI: Quality Metric Incorporated, 2012
   Google Scholar
• Gandek B, Ware JE Jr, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1149-58
   PubMed Web of Science ®Google Scholar
• Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res 2001;10:405-13
   PubMed Web of Science ®Google Scholar
• Badia X, Muriel C, Gracia A, et al. Validation of the Spanish version of the brief Pain Inventory in patients with oncological pain. Med Clin (Barc) 2003;120:52-9
   PubMed Web of Science ®Google Scholar
• González-Escalada JR, Camba A, Muriel C, et al. Validación del índice de Lattinen para la evaluación del paciente con dolor crónico [Validation of the Lattinen Index for the evaluation of patients with chronic pain]. Rev Soc Esp Dolor 2012;19:181-8
   Google Scholar
• Bruera E, Kuehn N, Miller M, et al. The Edmonton Symptom Assessment System (ESAS): simple method for assessment of palliative care patients. J Palliat Care 1991;7:6-9
   PubMedGoogle Scholar
• Caraceni A, Chemy N, Fainsinger R, et al. the Steering Committee of the EAPC Research Network. Pain measurement tools and methods in clinical research in palliative care: recommendations of an expert working group of the European Association of Palliative Care. J Pain Symptom Manage 2002;23:239-55
   PubMed Web of Science ®Google Scholar
• Vilagut G, Valdras JM, Ferrer M, et al. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental [Interpretation of health questionnaires SF-36 and SF-12 in Spain: physical and mental components]. Med Clin (Barc) 2008;130:726-35
   PubMed Web of Science ®Google Scholar